Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.
about
Myxoid fibroadenomas differ from conventional fibroadenomas: a hypothesis-generating study.MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathwaysHeritable and acquired disorders of phosphate metabolism: Etiologies involving FGF23 and current therapeutics.SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation.Recent translational research into targeted therapy for liposarcoma.Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast.Size and heterologous elements predict metastases in malignant phyllodes tumours of the breast.MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours.Comprehensive genomic profiling of malignant phyllodes tumors of the breast.
P2860
Q36373960-71218F25-7B20-40CE-B8E1-0C146FE34D7EQ37708965-FD3375B9-CB7F-4658-9E8E-E95BE8F5CCB2Q39118846-1DB3B775-DF3E-41FF-90E9-EE5F9E1E59AFQ39118911-04284173-464C-4FBD-82A0-5615F46C660DQ39265801-D0A7291B-07A8-4ABF-87E1-B944D2FBA623Q41195725-89D0B0C2-91C9-49BB-8796-8D205FBFC1AAQ47176937-337455C2-9BFB-473B-BD99-AA4083E870BFQ50120771-D089481A-0D10-4626-819B-14DBB18A966EQ52905583-D0706D23-7E9B-4578-BDF2-0039A885439B
P2860
Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Genomic profiling of malignant ...... to intratumoral heterogeneity.
@en
Genomic profiling of malignant ...... to intratumoral heterogeneity.
@nl
type
label
Genomic profiling of malignant ...... to intratumoral heterogeneity.
@en
Genomic profiling of malignant ...... to intratumoral heterogeneity.
@nl
prefLabel
Genomic profiling of malignant ...... to intratumoral heterogeneity.
@en
Genomic profiling of malignant ...... to intratumoral heterogeneity.
@nl
P2093
P2860
P50
P1433
P1476
Genomic profiling of malignant ...... nto intratumoral heterogeneity
@en
P2093
Ajay Ravindranathan
Bradley A Stohr
Courtney Onodera
Elizabeth Hosfield
Gregor Krings
James P Grenert
Jessica A Van Ziffle
Nancy M Joseph
Nancy Y Greenland
Poonam Vohra
P2860
P2888
P304
P356
10.1038/MODPATHOL.2016.97
P577
2016-06-03T00:00:00Z